Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial.
Metz M, Sussman G, Gagnon R, Staubach P, Tanus T, Yang WH, Lim JJ, Clarke HJ, Galanter J, Chinn LW, Chu T, Teterina A, Burgess T, Haddon DJ, Lu TT, Maurer M.
Metz M, et al. Among authors: maurer m.
Nat Med. 2021 Nov;27(11):1961-1969. doi: 10.1038/s41591-021-01537-w. Epub 2021 Nov 8.
Nat Med. 2021.
PMID: 34750553
Free PMC article.
Clinical Trial.